Abstract
A change in conceptual thinking about the pathogenesis of schizophrenia has occurred over the past decades. It is now hypothesized that the disorder has its origin on brain developmental neuropathology. The so-called neurodevelopmental hypothesis proposes that schizophrenia is related to adverse conditions leading to abnormal brain development during the pre- or postnatal period. This consequently leads to long-term changes in brain structure and brain malfunction, predisposing in term to functional deficits and to symptoms that respond to antidopaminergic drugs (Weinberger 1996).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams, W., Kendell, R.E., Hare, E.H., & Munk-Jorgensen, P. (1993) Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br J Psychiatry 163: 522–534
Akbarian, S., Bunney, W.E. JR., Potkin, S.G., Wigal, S.B., Hagman, J.O., Sandman, C.A., & Jones, E.G. (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50: 169–177
Akbarian, S., Vinuela, A., Kim, J.J., Potkin, S.G., Bunney, W.E. Jr., & Jones, E.G. (1993b) Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50: 178–187
Andreasen, N.C. (1999) A unitary model of schizophrenia: Bleuler’s “fragmented phrene” as schizencephaly. Arch Gen Psychiatry 56: 781–78
Arnold, S.E. (1997) The medial temporal lobe in schizophrenia. J Neuropsychiatry Clin Neurosci 9: 460–470
Arnold, S.E., Franz, B.R., Gur, R.C., Gur, R.E., Shapiro, R.M., Moberg, P.J., & Trojanowski, J.Q. (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical–hippocampal interactions. Am J Psychiatry 152: 738–748
Arnold, S.E., Lee, V.M., Gur, R.E., & Trojanowski, J.Q. (1991) Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 88: 10850–10854
Aston, C., Jiang, L., & Sokolov, B.P. (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77: 858–866
Aylward, E., Walker, E., & Bettes, B. (1984) Intelligence in schizophrenia: meta-analysis of the research. Schizophr Bull 10: 430–459
Baldessarini, R.J., Hegarty, J.D., Bird, E.D., & Benes, F.M. (1997) Meta-analysis of postmortem studies of Alzheimer’s disease-like neuropathology in schizophrenia. Am J Psychiatry 154: 861–863
Becker, A., Grecksch, G., Bernstein, H.G., Hollt, V., & Bogerts, B. (1999) Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl) 144: 333–338
Benes, F.M. (1989) Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull 15: 585–593
Benes, F.M., Kwok, E.W., Vincent, S.L., & Todtenkopf, M.S. (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44: 88–97
Benes, F.M., Mcsparren, J., Bird, E.D., Sangiovanni, J.P., & Vincent, S.L. (1991a) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996–1001
Benes, F.M., Sorensen, I., & Bird, E.D. (1991b) Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 17: 597–608
Benes, F.M., Turtle, M., Khan, Y., & Farol, P. (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 51: 477–484
Bernstein, H.G., Krell, D., Baumann, B., Danos, P., Falkai, P., Diekmann, S., Henning, H., & Bogerts, B. (1998) Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res 33: 125–132
Bertolino, A., Saunders, R.C., Mattay, V.S., Bachevalier, J., Frank, J.A., & Weinberger, D.R. (1997) Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 7: 740–748
Bogerts, B., Ashtari, M., Degreef, G., Alvir, J.M., Bilder, R.M., & Lieberman, J.A. (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 35: 1–13
Bogerts, B., Meertz, E., & Schonfeldt-Bausch, R. (1985) Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42: 784–791
Brown, A.S., Begg, M.D., Gravenstein, S., Schaefer, C.A., Wyatt, R.J., Bresnahan, M., Babulas, V.P., & Susser, E.S. (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61: 774–780
Brown, A.S., Susser, E.S., Butler, P.D., Richardson Andrews, R., Kaufmann, C.A., & Gorman, J.M. (1996) Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J Nerv Ment Dis 184: 71–85
Byne, W., Kidkardnee, S., Tatusov, A., Yiannoulos, G., Buchsbaum, M.S. & Haroutunian, V. (2006) Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res 85: 245–253
Callicott, J.H., Egan, M.F., Bertolino, A., Mattay, V.S., Langheim, F.J., Frank, J.A., & Weinberger, D.R. (1998) Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 44: 941–950
Cannon, T.D., Kaprio, J., Lonnqvist, J., Huttunen, M., & Koskenvuo, M. (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55: 67–74
Casanova, M.F., & Rothberg B. (2002) Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia. Schizophr Res 55: 19–24
Chambers, R.A., Moore, J., Mcevoy, J.P., & Levin, E.D. (1996) Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15: 587–594
Chaudhury, A.R., Gerecke, K.M., Wyss, J.M., Morgan, D.G., Gordon, M.N., & Carroll, S.L. (2003) Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 62: 42–54
Christison, G.W., Casanova, M.F., Weinberger, D.R., Rawlings, R., & Kleinman, J.E. (1989) A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 46: 1027–1032
Colter, N., Battal, S., Crow, T.J., Johnstone, E.C., Brown, R., & Bruton, C. (1987) White matter reduction in the parahippocampal gyrus of patients with schizophrenia. Arch Gen Psychiatry 44: 1023
Conrad, A.J., Abebe, T., Austin, R., Forsythe, S., & Scheibel, A.B. (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 48: 413–417
Cotter, D., Kerwin, R., Doshi, B., Martin, C.S., & Everall, I.P. (1997) Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 765: 238–46
Crow, T.J. (2007) How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 164: 13–21
Crow, T.J., Ball, J., Bloom, S. R., Brown, R., Bruton, C.J., Colter, N., Frith, C.D., Johnstone, E.C., Owens, D.G., & Roberts, G.W. (1989) Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 46: 1145–1150
Davis, K.L., Stewart, D.G., Friedman, J.I., Buchsbaum, M., Harvey, P.D., Hof, P.R., Buxbaum, J., & Haroutunian, V. (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60: 443–456
Dracheva, S., Davis, K.L., Chin, B., Woo, D.A., Schmeidler, J., & Haroutunian, V. (2006) Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis 21: 531–540
Eyler, L.T., Jeste, D.V., & Brown, G.G. (2008) Brain response abnormalities during verbal learning among patients with schizophrenia. Psychiatry Res 162: 11–25
Falkai, P., & Bogerts B. (1986) Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 236: 154–161
Falkai, P., Bogerts, B., Greve, B., Pfeiffer, U., Machus, B., Folsch-Reetz, B., Majtenyi, C., & Ovary, I. (1992) Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study. Schizophr Res 7: 23–32
Falkai, P., Bogerts, B., & Rozumek, M. (1988) Limbic pathology in schizophrenia: the entorhinal region – a morphometric study. Biol Psychiatry 24: 515–521
Falkai, P., Honer, W.G., David, S., Bogerts, B., Majtenyi, C., & Bayer, T.A. (1999) No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol 25: 48–53
Falkai, P., Schneider-Axmann, T., & Honer, W.G. (2000) Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47: 937–943
Falls, D.L. (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284: 14–30
Friston, K.J., & Frith C.D. (1995) Schizophrenia: a disconnection syndrome? Clin Neurosci 3: 89–97
Gerecke, K.M., Wyss, J.M., & Carroll, S.L. (2004) Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons. Mol Cell Neurosci 27: 379–393
Goldman-Rakic, P.S., Selemon, L.D., & Schwartz, M.L. (1984) Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12: 719–743
Grecksch, G., Bernstein, H.G., Becker, A., Hollt, V., & Bogerts, B. (1999) Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20: 525–532
Green, M.F., Satz, P., Gaier, D.J., Ganzell, S., & Kharabi, F. (1989) Minor physical anomalies in schizophrenia. Schizophr Bull 15: 91–99
Gruber, O., Falkai, P., Schneider-Axmann, T., Schwab, S.G., Wagner, M., & Maier, W. (2008) Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. J Psychiatr Res 19: 19
Hakak, Y., Walker, J.R., Li, C., Wong, W.H., Davis, K.L., Buxbaum, J.D., Haroutunian, V., & Fienberg, A.A. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746–4751
Hall, J., Whalley, H.C., Job, D.E., Baig, B.J., Mcintosh, A.M., Evans, K.L., Thomson, P.A., Porteous, D.J., Cunningham-Owens, D.G., Johnstone, E.C., & Lawrie, S.M. (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9: 1477–1478
Harrison, P.J., & Eastwood S.L. (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11: 508–519
Harrison, P.J., & Weinberger D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40–68
Heckers, S., Heinsen, H., Geiger, B., & Beckmann, H. (1991) Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 48: 1002–1008
Highley, J.R., Walker, M.A., McDonald, B., Crow, T.J., & Esiri, M.M. (2003) Size of hippocampal pyramidal neurons in schizophrenia. Br J Psychiatry 183: 414–417
Hirayasu, Y., Shenton, M.E., Salisbury, D.F., Dickey, C.C., Fischer, I.A., Mazzoni, P., Kisler, T., Arakaki, H., Kwon, J.S., Anderson, J.E., Yurgelun-Todd, D., Tohen, M., & Mccarley, R.W. (1998) Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry 155: 1384–1391
Hof, P.R., Haroutunian, V., Copland, C., Davis, K.L., & Buxbaum, J.D. (2002) Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 27: 1193–1200
Hong, L.E., Wonodi, I., Stine, O.C., Mitchell, B.D., Thaker, G.K. (2008) Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry 63: 17–23
Jakob, H., & Beckmann H. (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303–326
Jaskiw, G.E., Juliano, D. M., Goldberg, T.E., Hertzman, M., Urow-Hamell, E., & Weinberger, D.R. (1994) Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizophr Res 14: 23–28
Jeste, D.V., & Lohr J.B. (1989) Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry 46: 1019–1024
Jones, P., Rodgers, B., Murray, R., & Marmot, M. (1994) Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344: 1398–1402
Kaplan, M.J., Lazoff, M., Kelly, K., Lukin, R., & Garver, D.L. (1990) Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics. Biol Psychiatry 27: 205–214
Katsel, P., Davis, K.L., & Haroutunian, V. (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79: 157–173
Kovalenko, S., Bergmann, A., Schneider-Axmann, T., Ovary, I., Majtenyi, K., Havas, L., Honer, W.G., Bogerts, B., & Falkai, P. (2003) Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry 36: S158–161
Kovelman, J.A., & Scheibel A.B. (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19: 1601–1621
Kwon, O.B., Longart, M., Vullhorst, D., Hoffman, D.A., & Buonanno, A. (2005) Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 25: 9378–9383
Lane, A., Kinsella, A., Murphy, P., Byrne, M., Keenan, J., Colgan, K., Cassidy, B., Sheppard, N., Horgan, R., Waddington, J.L., Larkin, C., & O’callaghan, E. (1997) The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychol Med 27: 1155–1164
Law, A.J., Lipska, B.K., Weickert, C.S., Hyde, T.M., Straub, R.E., Hashimoto, R., Harrison, P.J., Kleinman, J.E., & Weinberger, D.R. (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5’ SNPs associated with the disease. Proc Natl Acad Sci USA 103: 6747–6752
Law, A.J., Shannon Weickert, C., Hyde, T.M., Kleinman, J.E., & Harrison, P.J. (2004a) Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127: 125–136
Law, A.J., Weickert, C.S., Hyde, T.M., Kleinman, J.E., & Harrison, P.J. (2004b) Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry 161: 1848–1855
Le Pen, G., Gaudet, L., Mortas, P., Mory, R., & Moreau, J.L. (2002) Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology (Berl) 161: 434–441
Li, D., Collier, D.A., & He, L. (2006) Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15: 1995–2002
Lim, K.O., Ardekani, B.A., Nierenberg, J., Butler, P.D., Javitt, D.C., & Hoptman, M.J. (2006) Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. Am J Psychiatry 163: 2008–2010
Lipska, B.K. (2004) Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J Psychiatry Neurosci 29: 282–286
Lipska, B.K., Aultman, J.M., Verma, A., Weinberger, D.R., & Moghaddam, B. (2002a) Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27: 47–54
Lipska, B.K., Halim, N.D., Segal, P.N., & Weinberger, D.R. (2002b) Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22: 2835–2842
Lipska, B.K., Jaskiw, G.E., & Weinberger, D.R. (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9: 67–75
Lipska, B.K., Swerdlow, N.R., Geyer, M.A., Jaskiw, G.E., Braff, D.L., & Weinberger, D.R. (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 122: 35–43
Lipska, B.K., & Weinberger D.R. (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23: 223–239
Maier, W., Zobel, A., & Rietschel, M. (2003) Genetics of schizophrenia and affective disorders. Pharmacopsychiatry 36: S195–202
McNeil, T.F., Cantor-Graae, E., Nordstrom, L.G., & Rosenlund, T. (1993) Head circumference in “preschizophrenic” and control neonates. Br J Psychiatry 162: 517–523
McNeil, T.F., Cantor-Graae, E., & Weinberger, D.R. (2000) Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry 157: 203–212
Munafo, M.R., Attwood, A.S., & Flint, J. (2008) Neuregulin 1 genotype and schizophrenia. Schizophr Bull 34: 9–12
Munafo, M.R., Thiselton, D.L., Clark, T.G., & Flint, J. (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11: 539–546
Nasrallah, H.A., Skinner, T.E., Schmalbrock, P., & Robitaille, P.M. (1994) Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 165: 481–485
Nordahl, T.E., Kusubov, N., Carter, C., Salamat, S., Cummings, A.M., O’SHORA-Celaya, L., Eberling, J., Robertson, L., Huesman, R.H., Jagust, W., & Budinger, T.F. (1996) Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology 15: 541–554
Parlapani, E., Schmitt, A., Wirths, O., Bauer, M., Sommer, C., Rueb, U., Skowronek, M.H., Treutlein, J., Petroianu, G.A., Rietschel, M., & Falkai, P. (2008) Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients. World J Biol Psychiatry 7: 1–8
Pegues, M.P., Rogers, L.J., Amend, D., Vinogradov, S., & Deicken, R.F. (2003) Anterior hippocampal volume reduction in male patients with schizophrenia. Schizophr Res 60: 105–115
Rametti, G., Segarra, N., Junque, C., Bargallo, N., Caldu, X., Ibarretxe, N., & Bernardo, M. (2007) Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia. Schizophr Res 961–3: 62–71
Rosoklija, G., Toomayan, G., Ellis, S.P., Keilp, J., Mann, J.J., Latov, N., Hays, A.P., & Dwork, A.J. (2000) Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 57: 349–356
Sams-Dodd, F., Lipska, B.K., & Weinberger, D.R. (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood Psychopharmacology (Berl) 132: 303–310
Saykin, A.J., Shtasel, D.L., Gur, R.E., Kester, D.B., Mozley, L.H., Stafiniak, P., & Gur, R.C. (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 51: 124–131
Schmitt, A., Parlapani, E., Gruber, O., Wobrock, T., & Falkai, P. (2008a) Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. Eur Arch Psychiatry Clin Neurosci 258: 35–39
Schmitt, A., Steyskal, C., Bernstein, H.G., Schneider-Axmann, T., Parlapani, E., Schaeffer, E.L., Gattaz, W.F., Bogerts, B., Schmitz, C., & Falkai, P. (2008b) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 6: 6
Seidman, L.J., Faraone, S.V., Goldstein, J.M., Kremen, W.S., Horton, N.J., Makris, N., Toomey, R., Kennedy, D., Caviness, V.S., & Tsuang, M.T. (2002) Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry 59: 839–849
Shenton, M.E., Dickey, C.C., Frumin, M., & Mccarley, R.W. (2001) A review of MRI findings in schizophrenia. Schizophr Res 49: 1–52
Stark, A.K., Uylings, H.B., Sanz-Arigita, E., & Pakkenberg, B. (2004) Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161: 882–888
Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T.T., Hjaltason, O., et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877–892
Stevens, J.R. (1982) Neuropathology of schizophrenia. Arch Gen Psychiatry 39: 1131–1139
Szeszko, P.R., Goldberg, E., Gunduz-Bruce, H., Ashtari, M., Robinson, D., Malhotra, A.K., Lencz, T., Bates, J., Crandall, D.T., Kane, J.M., & Bilder, R.M. (2003) Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. Am J Psychiatry 160: 2190–2197
Talamini, L.M., Meeter, M., Elvevag, B., Murre, J.M., & Goldberg, T.E. (2005) Reduced parahippocampal connectivity produces schizophrenia-like memory deficits in simulated neural circuits with reduced parahippocampal connectivity. Arch Gen Psychiatry 62: 485–493
Tregellas, J.R., Tanabe, J.L., Miller, D.E., Ross, R.G., Olincy, A., & Freedman, R. (2004) Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study. Am J Psychiatry 161: 315–321
Uranova, N.A., Vostrikov, V.M., Vikhreva, O.V., Zimina, I.S., Kolomeets, N.S., & Orlovskaya, D.D. (2007) The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol 10: 537–545
Van Erp, T.G., Saleh, P.A., Rosso, I.M., Huttunen, M., Lonnqvist, J., Pirkola, T., Salonen, O., Valanne, L., Poutanen, V.P., Standertskjold-Nordenstam, C.G., & Cannon, T.D. (2002) Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 159: 1514–1520
Velakoulis, D., Pantelis, C., Mcgorry, P.D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., Singh, B., & Copolov, D. (1999) Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry 56: 133–141
Velakoulis, D., Stuart, G.W., Wood, S.J., Smith, D.J., Brewer, W.J., Desmond, P., Singh, B., Copolov, D., & Pantelis, C. (2001) Selective bilateral hippocampal volume loss in chronic schizophrenia. Biol Psychiatry 50: 531–539
Walker, M.A., Highley, J.R., Esiri, M.M., Mcdonald, B., Roberts, H.C., Evans, S.P., & Crow, T.J. (2002) Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry 159: 821–828
Wan, R.Q., Giovanni, A., Kafka, S.H., & Corbett, R. (1996) Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav Brain Res 78: 211–223
Weinberger, D.R. (1996) On the plausibility of “the neurodevelopmental hypothesis” of schizophrenia. Neuropsychopharmacology 14: 1S–11S
Weinberger, D.R. (1999)Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45: 395–402
Winterer, G., Konrad, A., Vucurevic, G., Musso, F., Stoeter, P., & Dahmen, N. (2008) Association of 5’ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. Neuroimage 40: 712–718
Wright, I.C., Rabe-Hesketh, S., Woodruff, P.W., David, A.S., Murray, R.M., & Bullmore, E.T. (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157: 16–25
Yamasue, H., Iwanami, A., Hirayasu, Y., Yamada, H., Abe, O., Kuroki, N., Fukuda, R., Tsujii, K., Aoki, S., Ohtomo, K., Kato, N., & Kasai, K. (2004) Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res 131: 195–207
Zaidel, D.W., Esiri, M.M., & Harrison, P.J. (1997a) The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med 27: 703–713
Zaidel, D.W., Esiri, M.M., & Harrison, P.J. (1997b) Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 154: 812–818
Zhang, Z., Sun, J., & Reynolds, G.P. (2002) A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chin Med J (Engl) 115: 819–823
Zhou, Y., Shu, N., Liu, Y., Song, M., Hao, Y., Liu, H., Yu, C., Liu, Z., & Jiang, T. (2008) Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia. Schizophr Res 100: 120–132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Falkai, P., Parlapani, E., Gruber, O., Schmitt, A. (2010). The Neuropathology of Schizophrenia: Central Role for the Hippocampus?. In: Gattaz, W., Busatto, G. (eds) Advances in Schizophrenia Research 2009. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0913-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0913-8_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0912-1
Online ISBN: 978-1-4419-0913-8
eBook Packages: MedicineMedicine (R0)